MedRx Co., Ltd (4586.T)
JPY 84.0
(-3.45%)
JPY 84.0
(-3.45%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -1.72 Billion JPY | -73.03% |
| 2022 | -994.02 Million JPY | 41.65% |
| 2021 | -1.7 Billion JPY | 3.33% |
| 2020 | -1.76 Billion JPY | -24.92% |
| 2019 | -1.41 Billion JPY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -1.62 Billion JPY | 5.67% |
| 2024 Q2 | -2.16 Billion JPY | -33.46% |
| 2023 Q3 | -1.86 Billion JPY | -40.72% |
| 2023 Q4 | -1.72 Billion JPY | 7.8% |
| 2023 Q1 | -839.04 Million JPY | 15.59% |
| 2023 FY | -1.72 Billion JPY | -73.11% |
| 2023 Q2 | -1.32 Billion JPY | -58.06% |
| 2022 Q3 | -1.09 Billion JPY | 0.0% |
| 2022 FY | -994.02 Million JPY | 41.65% |
| 2022 Q4 | -994.02 Million JPY | 9.12% |
| 2021 FY | -1.7 Billion JPY | 3.33% |
| 2020 FY | -1.76 Billion JPY | -24.92% |
| 2019 FY | -1.41 Billion JPY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 1.22 Billion JPY | 240.408% |
| Takeda Pharmaceutical Company Limited | 4385.95 Billion JPY | 100.039% |
| Sumitomo Pharma Co., Ltd. | 389.83 Billion JPY | 100.441% |
| Shionogi & Co., Ltd. | -346.47 Billion JPY | 99.504% |
| Wakamoto Pharmaceutical Co.,Ltd. | -3.56 Billion JPY | 51.741% |
| Nippon Shinyaku Co., Ltd. | -42.15 Billion JPY | 95.92% |
| Kaken Pharmaceutical Co., Ltd. | -61.47 Billion JPY | 97.202% |
| Eisai Co., Ltd. | -97.93 Billion JPY | 98.244% |
| Morishita Jintan Co., Ltd. | -667 Million JPY | -157.871% |
| Hisamitsu Pharmaceutical Co., Inc. | -51.82 Billion JPY | 96.681% |
| Mochida Pharmaceutical Co., Ltd. | -32.92 Billion JPY | 94.775% |
| Fuso Pharmaceutical Industries,Ltd. | 7.6 Billion JPY | 122.626% |
| Nippon Chemiphar Co., Ltd. | 7.78 Billion JPY | 122.105% |
| Tsumura & Co. | 1.61 Billion JPY | 206.502% |
| Kissei Pharmaceutical Co., Ltd. | -44.16 Billion JPY | 96.105% |
| Torii Pharmaceutical Co., Ltd. | -34.43 Billion JPY | 95.005% |
| Towa Pharmaceutical Co., Ltd. | 172.7 Billion JPY | 100.996% |
| Fuji Pharma Co., Ltd. | 26.62 Billion JPY | 106.46% |
| Zeria Pharmaceutical Co., Ltd. | 28.98 Billion JPY | 105.935% |
| KYORIN Holdings, Inc. | 7.06 Billion JPY | 124.363% |
| Taiko Pharmaceutical Co.,Ltd. | 704 Million JPY | 344.318% |
| Daito Pharmaceutical Co.,Ltd. | 5.99 Billion JPY | 128.705% |
| SymBio Pharmaceuticals Limited | -6.51 Billion JPY | 73.608% |
| Mizuho Medy Co.,Ltd. | -8.71 Billion JPY | 80.267% |
| Solasia Pharma K.K. | -668 Million JPY | -157.485% |
| Modalis Therapeutics Corporation | -1.47 Billion JPY | -16.932% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | -7.25 Billion JPY | 76.286% |
| Sawai Group Holdings Co., Ltd. | 56.52 Billion JPY | 103.043% |
| Cyfuse Biomedical K.K. | -2.96 Billion JPY | 41.907% |
| Toho Holdings Co., Ltd. | -98.42 Billion JPY | 98.253% |
| Koa Shoji Holdings Co.,Ltd. | -11.12 Billion JPY | 84.546% |